Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Net Income (2020 - 2025)

Historic Net Income for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $15.9 million.

  • Tango Therapeutics' Net Income rose 15445.88% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.5 million, marking a year-over-year increase of 1856.67%. This contributed to the annual value of -$130.3 million for FY2024, which is 2806.85% down from last year.
  • According to the latest figures from Q3 2025, Tango Therapeutics' Net Income is $15.9 million, which was up 15445.88% from -$38.9 million recorded in Q2 2025.
  • Over the past 5 years, Tango Therapeutics' Net Income peaked at $15.9 million during Q3 2025, and registered a low of -$39.9 million during Q1 2025.
  • In the last 5 years, Tango Therapeutics' Net Income had a median value of -$25.6 million in 2024 and averaged -$24.3 million.
  • In the last 5 years, Tango Therapeutics' Net Income crashed by 95180677.97% in 2021 and then soared by 15445.88% in 2025.
  • Tango Therapeutics' Net Income (Quarter) stood at -$22.1 million in 2021, then plummeted by 31.98% to -$29.1 million in 2022, then dropped by 5.65% to -$30.8 million in 2023, then dropped by 22.37% to -$37.6 million in 2024, then skyrocketed by 142.21% to $15.9 million in 2025.
  • Its Net Income stands at $15.9 million for Q3 2025, versus -$38.9 million for Q2 2025 and -$39.9 million for Q1 2025.